4-127811540-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014278.4(HSPA4L):c.1482C>A(p.Ser494Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000439 in 1,613,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00046 ( 0 hom. )
Consequence
HSPA4L
NM_014278.4 missense
NM_014278.4 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 0.672
Genes affected
HSPA4L (HGNC:17041): (heat shock protein family A (Hsp70) member 4 like) The protein encoded by this gene is heat shock inducible and may act as a chaperone. The encoded protein can protect the heat-shocked cell against the harmful effects of aggregated proteins. This gene is highly expressed in leukemia cells and may be a good target for therapeutic intervention. Several transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
BP4
?
Computational evidence support a benign effect (MetaRNN=0.09493652).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HSPA4L | NM_014278.4 | c.1482C>A | p.Ser494Arg | missense_variant | 12/19 | ENST00000296464.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HSPA4L | ENST00000296464.9 | c.1482C>A | p.Ser494Arg | missense_variant | 12/19 | 1 | NM_014278.4 | P1 | |
HSPA4L | ENST00000508549.5 | c.1359C>A | p.Ser453Arg | missense_variant | 11/13 | 1 | |||
HSPA4L | ENST00000508776.5 | c.1482C>A | p.Ser494Arg | missense_variant | 13/20 | 2 | P1 | ||
HSPA4L | ENST00000505726.1 | c.1404C>A | p.Ser468Arg | missense_variant | 12/19 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000237 AC: 36AN: 151934Hom.: 0 Cov.: 31
GnomAD3 genomes
?
AF:
AC:
36
AN:
151934
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251298Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135808
GnomAD3 exomes
AF:
AC:
51
AN:
251298
Hom.:
AF XY:
AC XY:
26
AN XY:
135808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000460 AC: 673AN: 1461510Hom.: 0 Cov.: 31 AF XY: 0.000432 AC XY: 314AN XY: 727082
GnomAD4 exome
AF:
AC:
673
AN:
1461510
Hom.:
Cov.:
31
AF XY:
AC XY:
314
AN XY:
727082
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000237 AC: 36AN: 152052Hom.: 0 Cov.: 31 AF XY: 0.000229 AC XY: 17AN XY: 74330
GnomAD4 genome
?
AF:
AC:
36
AN:
152052
Hom.:
Cov.:
31
AF XY:
AC XY:
17
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
?
AF:
AC:
19
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2022 | The c.1482C>A (p.S494R) alteration is located in exon 12 (coding exon 12) of the HSPA4L gene. This alteration results from a C to A substitution at nucleotide position 1482, causing the serine (S) at amino acid position 494 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
DEOGEN2
Benign
T;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;T;D
Polyphen
D;D;.;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0185);Gain of MoRF binding (P = 0.0185);.;.;
MVP
MPC
0.64
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at